Engineering Cell Density with Nanoparticles for Superior Stem Cell Engraftment

Stem cell-based therapies hold substantial promise for tissue repair, inflammation control, and anti-fibrotic treatment. However, their clinical translation remains constrained by the poor retention and engraftment of transplanted cells at target sites. A large fraction of administered cells is rapidly lost because of weak initial adhesion, mechanical washout, and a hostile local microenvironment, resulting in limited therapeutic efficacy. Although genetic engineering, chemical surface functionalization, and biomaterial encapsulation have been explored to improve cell retention, these strategies may introduce concerns regarding safety, manufacturing complexity, regulatory approval, and clinical feasibility. Therefore, there is a strong need for simple, safe, and translationally relevant approaches that enhance cell localization and persistence without extensively altering cellular identity or function. This presentation presents a nanoparticle-enabled biophysical strategy to improve the retention and therapeutic performance of mesenchymal stem cells (MSCs). Cell-settling nanoparticles composed of clinically approved materials were incorporated into MSCs to increase cellular density. This density modulation accelerated gravitational settling, promoted early adhesion to the target surface, and improved cell survival. Building on this physical approach, copper-chaperone-activatable nanoparticles were developed to further enhance tissue regeneration and anti-fibrotic activity. These nanoparticles activated fibroblast growth factor 2 (FGF2)-related signaling and generated a positive feedback loop that supported pro-regenerative cellular responses. In a mouse skin wound model, MSCs treated with copper-chaperone-activatable nanoparticles demonstrated enhanced vascularization and reduced fibrosis compared with conventional cell transplantation approaches. These findings indicate that controlling cellular density and physical forces can improve stem cell engraftment and regenerative outcomes. This biophysical framework provides a potentially safer and more clinically practical alternative to conventional cell-engineering strategies, opening new opportunities for the development of effective cell-based therapies.